Cargando…
Iodine-125 Brachytherapy Prophylaxis after Radiofrequency Ablation Cannot Benefit Patients in High Risk of Locoregional Hepatocellular Carcinoma Recurrence
This study evaluated if iodine-125 brachytherapy prophylaxis after radiofrequency ablation (RFA) prolongs time to recurrence (TTR) and overall survival (OS) of patients in high risk of locoregional hepatocellular carcinoma (HCC) recurrence. 116 patients with total tumor necrosis after RFA were divid...
Autores principales: | Tu, Jian-Fei, Ding, Ya-Hui, Chen, Li, Ying, Xi-Hui, Zhang, Deng-Ke, Wu, Fa-Zong, Zhao, Zhong-Wei, Ji, Jian-Song, Zhang, Wang-Gang, Zou, Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473839/ https://www.ncbi.nlm.nih.gov/pubmed/28623296 http://dx.doi.org/10.1038/s41598-017-03831-5 |
Ejemplares similares
-
Radiofrequency ablation versus (125)I-seed brachytherapy for painful metastases involving the bone
por: Jiao, Dechao, et al.
Publicado: (2016) -
Impact of target area selection in (125)
Iodine seed brachytherapy on locoregional recurrence in patients with non‐small cell lung cancer
por: Yan, Wei‐Liang, et al.
Publicado: (2017) -
Safety and efficacy of iodine-125 seed strand for intraluminal brachytherapy on ureteral carcinoma
por: Bi, Yonghua, et al.
Publicado: (2023) -
A Robust Oxygen Microbubble Radiosensitizer for Iodine‐125 Brachytherapy
por: Peng, Sheng, et al.
Publicado: (2021) -
Iodine-125 brachytherapy for brain tumours - a review
por: Schwarz, Silke B, et al.
Publicado: (2012)